Is Seelos Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SEEL) stock is to Strong Buy SEEL stock.
Out of 2 analysts, 1 (50%) are recommending SEEL as a Strong Buy, 1 (50%) are recommending SEEL as a Buy, 0 (0%) are recommending SEEL as a Hold, 0 (0%) are recommending SEEL as a Sell, and 0 (0%) are recommending SEEL as a Strong Sell.
What is SEEL's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: SEEL) forecast ROE is N/A, which is considered weak.
What is SEEL's Price Target?
According to 2 Wall Street analysts that have issued a 1 year SEEL price target, the average SEEL price target is $45.00, with the highest SEEL stock price forecast at $60.00 and the lowest SEEL stock price forecast at $30.00.
On average, Wall Street analysts predict that Seelos Therapeutics's share price could reach $45.00 by Sep 21, 2024. The average Seelos Therapeutics stock price prediction forecasts a potential upside of 2,610.84% from the current SEEL share price of $1.66.
What is SEEL's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: SEEL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.